Why not use the HbA1c as a criterion of dysglycemia in the new definition of the metabolic syndrome? Impact of the new criteria in the prevalence of the metabolic syndrome in a Mediterranean urban population from Southern Europe (IMAP study. Multidisciplinary intervention in primary care).

@article{BernalLpez2011WhyNU,
  title={Why not use the HbA1c as a criterion of dysglycemia in the new definition of the metabolic syndrome? Impact of the new criteria in the prevalence of the metabolic syndrome in a Mediterranean urban population from Southern Europe (IMAP study. Multidisciplinary intervention in primary care).},
  author={Maria Rosa Bernal-L{\'o}pez and Aurora Villalobos-Sanchez and Jose Mancera-Romero and Sergio Jansen-Chaparro and Antonio J Baca-Osorio and Maria Dolores Lopez-Carmona and Francisco J Tinahones and Ricardo G{\'o}mez-Huelgas},
  journal={Diabetes research and clinical practice},
  year={2011},
  volume={93 2},
  pages={e57-60}
}
We analysed the prevalence of metabolic syndrome (MS) of the new diagnostic criteria and the HbA1c to diagnose dysglycemia. We studied 2006 adults without cardiovascular disease or diabetes. The use of the new criteria and the HbA1c resulted in an increase in the population prevalence of MS. 

From This Paper

Topics from this paper.